Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes

Single-Nucleotide Polymorphism Array Technique Generating Valuable Risk-Stratification Information for Patients With Myelodysplastic Syndromes

Background: Chromosomal abnormalities play an important role in the diagnosis and prognosis of patients with myelodysplastic syndromes (MDSs). The single-nucleotide polymorphism array (SNP-A) technique has gained popularity due to its improved resolution compared to that of metaphase cytogenetic (MC...

Full description

Bibliographic Details
Main Authors:	Xia Xiao, Xiaoyuan He, Qing Li, Wei Zhang, Haibo Zhu, Weihong Yang, Yuming Li, Li Geng, Hui Liu, Lijuan Li, Huaquan Wang, Rong Fu, Mingfeng Zhao, Zhong Chen, Zonghong Shao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Oncology
Subjects:	myelodysplastic syndrome (MDS) idiopathic cytopenia of undetermined significance (ICUS) single-nucleotide polymorphism (SNP) chromosome aberrations prognosis
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00962/full

Similar Items

Idiopathic Fatal Pancytopenia: A Case Report
by: Hema Goyal, et al.
Published: (2016-06-01)

Summary of animal models of myelodysplastic syndrome
by: Weisha Li, et al.
Published: (2021-03-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Autoimmune syndromes presenting as a paraneoplastic manifestation of myelodysplastic syndromes: clinical features, course, treatment and outcome
by: Bradley T. Williamson, et al.
Published: (2016-05-01)

Management of Adult Patients with Myelodysplastic Syndromes
by: Nicolas Bonadies
Published: (2017-08-01)

An analysis of the demographic profile, clinical manifestations, investigations and outcome of paediatric myelodysplastic syndrome: A single centre, cross-sectional study
by: Appaji Lingegowda, et al.
Published: (2015-09-01)

Acute leukemia / myelodysplastic syndrome as a sequelae of carcinoma breast: A report of five cases from north India
by: Bhatia Prateek, et al.
Published: (2009-04-01)

Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)
by: Michele Stanchina, et al.
Published: (2021-04-01)

Novel spontaneous myelodysplastic syndrome mouse model
by: Weisha Li, et al.
Published: (2021-06-01)

Myelodysplastic syndrome: classification and changing concept
by: A Ghosh
Published: (2011-10-01)

Síndromes mielodisplásticas: diagnóstico de exclusão Myelodysplastic syndromes: diagnosis by exclusion
by: Silvia M. M. Magalhães
Published: (2006-09-01)

Síndromes mielodisplásicas: protocolo de exclusão Myelodysplastic syndrome: diagnostic protocol
by: Silvia Maria M. Magalhães, et al.
Published: (2004-12-01)

The acquisition of trisomy 8 associated with Behçet's-like disease in myelodysplastic syndrome
by: Satoko Oka, et al.
Published: (2020-01-01)

Nonclonal chromosomal alterations and poor survival in cytopenic patients without hematological malignancies
by: Osamu Imataki, et al.
Published: (2019-11-01)

Membranous glomerulonephritis in a patient with myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia
by: Kwang Il Ko, et al.
Published: (2013-09-01)

Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC)
by: Ni Komang Ayu Parmawati, et al.
Published: (2019-08-01)

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study
by: Galimberti Sara, et al.
Published: (2012-09-01)

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
by: Čermák Jaroslav, et al.
Published: (2011-10-01)

Myelodysplastic syndrome among elderly patients with anemia: A Single institutional experience
by: Karuna Rameshkumar, et al.
Published: (2018-01-01)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
by: Jacob Shreve, et al.
Published: (2020-04-01)

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
by: Jan Philipp Bewersdorf, et al.
Published: (2021-03-01)

Síndrome mielodisplásica secundária à quimio ou radioterapia: SMD relacionada a tratamento Myelodysplastic syndrome secondary to chemo: and radiotherapy MDS related to the treatment
by: Ronald F. Pinheiro, et al.
Published: (2006-09-01)

Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies
by: Nina Kim, et al.
Published: (2018-08-01)

Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation
by: Olga Blau, et al.
Published: (2016-11-01)

Management of myelodysplastic syndromes: Expert consensus opinion from the Saudi MDS Working Group
by: Ahmed Alaskar, et al.
Published: (2014-01-01)

Missing cells: pathophysiology, diagnosis and management of (pan)cytopenia in childhood
by: Miriam eErlacher, et al.
Published: (2015-07-01)

Aberrations of chromosome 8 in myelodysplastic syndromes: Clinical and biological significance
by: Marisavljević Dragomir, et al.
Published: (2006-01-01)

Dispositivo para medição e controle da pressão do balonete das proteses traqueais
by: NASCIMENTO, Jadiel da Silva
Published: (2017)

The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome
by: Wen-Chi Yang, et al.
Published: (2020-04-01)

An assessment of nurses' knowledge regarding noise in intensive care units in Jordan
by: Omar M. Al-Tarawneh, et al.
Published: (2020-01-01)

Atypia and Follicular Lesions of Undetermined Significance in Subsequent Biopsy Result: What Clinicians Need to Know
by: Krzysztof Kaliszewski, et al.
Published: (2021-07-01)

GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes
by: Antonella Bruzzese, et al.
Published: (2020-10-01)

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population
by: Belickova Monika, et al.
Published: (2013-01-01)

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes
by: Joseph A. Clara, et al.
Published: (2016-09-01)

Abnormal Ferroptosis in Myelodysplastic Syndrome
by: Qi Lv, et al.
Published: (2020-09-01)

Malignancy rate in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance - An institutional experience
by: Smita Chandra, et al.
Published: (2017-01-01)

Síndrome mielodisplásica na infância Myelodysplastic syndromes in childhood
by: Luiz F. Lopes, et al.
Published: (2006-09-01)

Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile
by: Aleksandar Radujkovic, et al.
Published: (2020-12-01)

Early detection of transformation to BPDCN in a patient with MDS
by: Kamal Chamoun, et al.
Published: (2018-10-01)

An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
by: Stuart L. Goldberg, et al.
Published: (2014-01-01)